A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Clinical utilization patterns of alvimopan in a contemporary cohort of patients undergoing radical cystectomy
OBJECTIVE: To evaluate the clinical utilization patterns and outcomes of alvimopan, a peripherally-acting µ-opioid receptor antagonist, after radical cystectomy (RC) and urinary diversion at a high-volume cancer center. PATIENTS AND METHODS: We retrospectively identified 130 consecutive patients who underwent RC and urinary diversion for bladder cancer at our institution from October 2013 to September 2014. Demographic, clinical, and postoperative outcomes were compared between patients who diddoi:10.14440/bladder.2015.48 fatcat:wg55ezivnrdrdncup33jfv2nka